Press Releases
Pfizer Launches Global Centers for Therapeutic Innovation, a Network...
Pfizer Inc. announced the establishment of the Global Centers for Therapeutic Innovation, an entrepreneurial network of partnerships with leading academic medical centers to...
Press Releases
Pfizer Inc, Study Shows Adding INSPRA to Standard Therapy...
Pfizer Inc. announced results from the EMPHASIS-HF trial(1) showing a statistically significant reduction in risk of cardiovascular (CV) death or heart failure (HF) hospitalization for...
Press Releases
Forest Laboratories Enters Collaboration on Bystolic(R) and Savella(R)
Forest Laboratories, Inc. announced that Forest Laboratories Holdings Limited, its wholly owned subsidiary, has entered into a definitive collaboration and distribution agreement for Bystolic(R) (nebivolol)...
Press Releases
Endo Pharmaceuticals Announces That FDA Eliminates Need for Advisory...
 Endo Pharmaceuticals announced that the U.S. FDA has informed the company that FDA no longer sees a need to convene a joint meeting of...
Press Releases
Abbott Wins Two Scrip Awards Recognizing Excellence in Pharmaceutical...
Abbott Park, Illinois Scrip, a leading global pharmaceutical and biotech news organization, honored Abbott with two 2010 Scrip Awards for its business excellence and strong...
Press Releases
Nycomed to acquire of majority stake in Guangdong Techpool...
Nycomed announced that it is significantly expanding its presence in China through the acquisition of a majority stake in Guangdong Techpool Bio-Pharma Co., Ltd. (Techpool),...
Press Releases
PTC Therapeutics Initiates Phase 2 Clinical Trial of Ataluren...
PTC Therapeutics, Inc. today announced that it is expanding the development of ataluren, an investigational new drug, with the initiation of a Phase 2 clinical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.